Activin-attenuated expression of transcripts encoding granulosa cell- derived insulin-like growth factor binding proteins 4 and 5 in the rat: A putative antiatretic effect

DooSeok Choi, Richard M. Rohan, Ronald (Ron) Rosenfeld, Tomoko Matsumoto, Sharron E. Gargosky, Eli Y. Adashi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Given the suggestion that intraovarian insulin-like growth factor (IGF)- binding proteins (IGFBPs) may constitute markers of follicular atresia, we investigated the possibility that activin, a putative antiatretic principle, may modulate granulosa cell-derived IGFBPs. Untreated granulosa cells cultured for 72 h exhibited a progressive increase in the steady-state levels of transcripts corresponding to IGFBP-4 and IGFBP-5 (1.5-fold and 12-fold, respectively). Transcript levels corresponding to IGFBP-5 were consistently higher than their IGFBP-4 counterparts. Treatment with activin-A (50 ng/ml) for 72 h produced significant (p <0.05) decrements in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts (46% and 79%, respectively) as compared to controls. Thus, treatment with activin-A appears to be capable of blocking the spontaneous increase in IGFBP-4 and IGFBP-5 transcripts exhibited by untreated cultured granulosa cells. Consistent activin-A- induced decrements were also observed in the accumulation of the IGFBP-5 (but not the IGFBP-4) protein. Dose-response analysis revealed monophasic dose dependence (half maximal inhibitory doses of 16.2 and 7.8 ng/ml for IGFBP-5 and IGFBP-4 transcripts, respectively). The addition of increasing concentrations of the putative activin-binding protein, follistatin, produced dose-dependent reversal of the activin-A effect on IGFBP transcripts (IGFBP- 5 > IGFBP-4). Activin-B was as effective as activin-A in reducing IGFBP-4 transcripts (31% decrement, p <0.05) whereas it had little or no effect on IGFBP-5 transcripts (21% decrement, p > 0.1). No apparent effect was observed for the corresponding proteins. Activin-A action was specific in that treatment with transforming growth factor (TGF)-β1, inhibin-A, or Mullerian-inhibiting substance (MIS)-all related peptides-failed to produce statistically significant alterations in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts. Taken together, these observations reveal that activin-A exerts a substantial, relatively rapid, follistatin-neutralizable, dose- and time-dependent inhibitory effect on granulosa cell-derived IGFBP transcripts (IGFBP-5 > IGFBP-4). Other members of the TGFβ superfamily (e.g., inhibin-A, TGFβ1, and MIS) were without significant effect on the expression of IGFBP-4 and IGFBP-5. To the extent that the inhibition of IGFBP-4 and IGFBP-5 expression is associated with, and possibly causally related to, the promotion of follicular health, the activin may play an antiatretic role in the dynamic process of follicular selection.

Original languageEnglish (US)
Pages (from-to)508-515
Number of pages8
JournalBiology of Reproduction
Volume56
Issue number2
DOIs
StatePublished - Feb 1997

Fingerprint

Insulin-Like Growth Factor Binding Protein 5
Insulin-Like Growth Factor Binding Protein 4
Activins
Granulosa Cells
Insulin-Like Growth Factor Binding Proteins
Anti-Mullerian Hormone
Transforming Growth Factors
Follicular Atresia
Follistatin
Health Promotion
Peptides

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Embryology

Cite this

Activin-attenuated expression of transcripts encoding granulosa cell- derived insulin-like growth factor binding proteins 4 and 5 in the rat : A putative antiatretic effect. / Choi, DooSeok; Rohan, Richard M.; Rosenfeld, Ronald (Ron); Matsumoto, Tomoko; Gargosky, Sharron E.; Adashi, Eli Y.

In: Biology of Reproduction, Vol. 56, No. 2, 02.1997, p. 508-515.

Research output: Contribution to journalArticle

Choi, DooSeok ; Rohan, Richard M. ; Rosenfeld, Ronald (Ron) ; Matsumoto, Tomoko ; Gargosky, Sharron E. ; Adashi, Eli Y. / Activin-attenuated expression of transcripts encoding granulosa cell- derived insulin-like growth factor binding proteins 4 and 5 in the rat : A putative antiatretic effect. In: Biology of Reproduction. 1997 ; Vol. 56, No. 2. pp. 508-515.
@article{59fa27a19fc54155a12bd4353c3bf611,
title = "Activin-attenuated expression of transcripts encoding granulosa cell- derived insulin-like growth factor binding proteins 4 and 5 in the rat: A putative antiatretic effect",
abstract = "Given the suggestion that intraovarian insulin-like growth factor (IGF)- binding proteins (IGFBPs) may constitute markers of follicular atresia, we investigated the possibility that activin, a putative antiatretic principle, may modulate granulosa cell-derived IGFBPs. Untreated granulosa cells cultured for 72 h exhibited a progressive increase in the steady-state levels of transcripts corresponding to IGFBP-4 and IGFBP-5 (1.5-fold and 12-fold, respectively). Transcript levels corresponding to IGFBP-5 were consistently higher than their IGFBP-4 counterparts. Treatment with activin-A (50 ng/ml) for 72 h produced significant (p <0.05) decrements in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts (46{\%} and 79{\%}, respectively) as compared to controls. Thus, treatment with activin-A appears to be capable of blocking the spontaneous increase in IGFBP-4 and IGFBP-5 transcripts exhibited by untreated cultured granulosa cells. Consistent activin-A- induced decrements were also observed in the accumulation of the IGFBP-5 (but not the IGFBP-4) protein. Dose-response analysis revealed monophasic dose dependence (half maximal inhibitory doses of 16.2 and 7.8 ng/ml for IGFBP-5 and IGFBP-4 transcripts, respectively). The addition of increasing concentrations of the putative activin-binding protein, follistatin, produced dose-dependent reversal of the activin-A effect on IGFBP transcripts (IGFBP- 5 > IGFBP-4). Activin-B was as effective as activin-A in reducing IGFBP-4 transcripts (31{\%} decrement, p <0.05) whereas it had little or no effect on IGFBP-5 transcripts (21{\%} decrement, p > 0.1). No apparent effect was observed for the corresponding proteins. Activin-A action was specific in that treatment with transforming growth factor (TGF)-β1, inhibin-A, or Mullerian-inhibiting substance (MIS)-all related peptides-failed to produce statistically significant alterations in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts. Taken together, these observations reveal that activin-A exerts a substantial, relatively rapid, follistatin-neutralizable, dose- and time-dependent inhibitory effect on granulosa cell-derived IGFBP transcripts (IGFBP-5 > IGFBP-4). Other members of the TGFβ superfamily (e.g., inhibin-A, TGFβ1, and MIS) were without significant effect on the expression of IGFBP-4 and IGFBP-5. To the extent that the inhibition of IGFBP-4 and IGFBP-5 expression is associated with, and possibly causally related to, the promotion of follicular health, the activin may play an antiatretic role in the dynamic process of follicular selection.",
author = "DooSeok Choi and Rohan, {Richard M.} and Rosenfeld, {Ronald (Ron)} and Tomoko Matsumoto and Gargosky, {Sharron E.} and Adashi, {Eli Y.}",
year = "1997",
month = "2",
doi = "10.1095/biolreprod56.2.508",
language = "English (US)",
volume = "56",
pages = "508--515",
journal = "Biology of Reproduction",
issn = "0006-3363",
publisher = "Society for the Study of Reproduction",
number = "2",

}

TY - JOUR

T1 - Activin-attenuated expression of transcripts encoding granulosa cell- derived insulin-like growth factor binding proteins 4 and 5 in the rat

T2 - A putative antiatretic effect

AU - Choi, DooSeok

AU - Rohan, Richard M.

AU - Rosenfeld, Ronald (Ron)

AU - Matsumoto, Tomoko

AU - Gargosky, Sharron E.

AU - Adashi, Eli Y.

PY - 1997/2

Y1 - 1997/2

N2 - Given the suggestion that intraovarian insulin-like growth factor (IGF)- binding proteins (IGFBPs) may constitute markers of follicular atresia, we investigated the possibility that activin, a putative antiatretic principle, may modulate granulosa cell-derived IGFBPs. Untreated granulosa cells cultured for 72 h exhibited a progressive increase in the steady-state levels of transcripts corresponding to IGFBP-4 and IGFBP-5 (1.5-fold and 12-fold, respectively). Transcript levels corresponding to IGFBP-5 were consistently higher than their IGFBP-4 counterparts. Treatment with activin-A (50 ng/ml) for 72 h produced significant (p <0.05) decrements in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts (46% and 79%, respectively) as compared to controls. Thus, treatment with activin-A appears to be capable of blocking the spontaneous increase in IGFBP-4 and IGFBP-5 transcripts exhibited by untreated cultured granulosa cells. Consistent activin-A- induced decrements were also observed in the accumulation of the IGFBP-5 (but not the IGFBP-4) protein. Dose-response analysis revealed monophasic dose dependence (half maximal inhibitory doses of 16.2 and 7.8 ng/ml for IGFBP-5 and IGFBP-4 transcripts, respectively). The addition of increasing concentrations of the putative activin-binding protein, follistatin, produced dose-dependent reversal of the activin-A effect on IGFBP transcripts (IGFBP- 5 > IGFBP-4). Activin-B was as effective as activin-A in reducing IGFBP-4 transcripts (31% decrement, p <0.05) whereas it had little or no effect on IGFBP-5 transcripts (21% decrement, p > 0.1). No apparent effect was observed for the corresponding proteins. Activin-A action was specific in that treatment with transforming growth factor (TGF)-β1, inhibin-A, or Mullerian-inhibiting substance (MIS)-all related peptides-failed to produce statistically significant alterations in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts. Taken together, these observations reveal that activin-A exerts a substantial, relatively rapid, follistatin-neutralizable, dose- and time-dependent inhibitory effect on granulosa cell-derived IGFBP transcripts (IGFBP-5 > IGFBP-4). Other members of the TGFβ superfamily (e.g., inhibin-A, TGFβ1, and MIS) were without significant effect on the expression of IGFBP-4 and IGFBP-5. To the extent that the inhibition of IGFBP-4 and IGFBP-5 expression is associated with, and possibly causally related to, the promotion of follicular health, the activin may play an antiatretic role in the dynamic process of follicular selection.

AB - Given the suggestion that intraovarian insulin-like growth factor (IGF)- binding proteins (IGFBPs) may constitute markers of follicular atresia, we investigated the possibility that activin, a putative antiatretic principle, may modulate granulosa cell-derived IGFBPs. Untreated granulosa cells cultured for 72 h exhibited a progressive increase in the steady-state levels of transcripts corresponding to IGFBP-4 and IGFBP-5 (1.5-fold and 12-fold, respectively). Transcript levels corresponding to IGFBP-5 were consistently higher than their IGFBP-4 counterparts. Treatment with activin-A (50 ng/ml) for 72 h produced significant (p <0.05) decrements in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts (46% and 79%, respectively) as compared to controls. Thus, treatment with activin-A appears to be capable of blocking the spontaneous increase in IGFBP-4 and IGFBP-5 transcripts exhibited by untreated cultured granulosa cells. Consistent activin-A- induced decrements were also observed in the accumulation of the IGFBP-5 (but not the IGFBP-4) protein. Dose-response analysis revealed monophasic dose dependence (half maximal inhibitory doses of 16.2 and 7.8 ng/ml for IGFBP-5 and IGFBP-4 transcripts, respectively). The addition of increasing concentrations of the putative activin-binding protein, follistatin, produced dose-dependent reversal of the activin-A effect on IGFBP transcripts (IGFBP- 5 > IGFBP-4). Activin-B was as effective as activin-A in reducing IGFBP-4 transcripts (31% decrement, p <0.05) whereas it had little or no effect on IGFBP-5 transcripts (21% decrement, p > 0.1). No apparent effect was observed for the corresponding proteins. Activin-A action was specific in that treatment with transforming growth factor (TGF)-β1, inhibin-A, or Mullerian-inhibiting substance (MIS)-all related peptides-failed to produce statistically significant alterations in the steady-state levels of IGFBP-4 and IGFBP-5 transcripts. Taken together, these observations reveal that activin-A exerts a substantial, relatively rapid, follistatin-neutralizable, dose- and time-dependent inhibitory effect on granulosa cell-derived IGFBP transcripts (IGFBP-5 > IGFBP-4). Other members of the TGFβ superfamily (e.g., inhibin-A, TGFβ1, and MIS) were without significant effect on the expression of IGFBP-4 and IGFBP-5. To the extent that the inhibition of IGFBP-4 and IGFBP-5 expression is associated with, and possibly causally related to, the promotion of follicular health, the activin may play an antiatretic role in the dynamic process of follicular selection.

UR - http://www.scopus.com/inward/record.url?scp=0031059169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031059169&partnerID=8YFLogxK

U2 - 10.1095/biolreprod56.2.508

DO - 10.1095/biolreprod56.2.508

M3 - Article

C2 - 9116154

AN - SCOPUS:0031059169

VL - 56

SP - 508

EP - 515

JO - Biology of Reproduction

JF - Biology of Reproduction

SN - 0006-3363

IS - 2

ER -